MedPath

Cost-effectiveness of Tele-expertise for Premature Infants for Retinopathy

Completed
Conditions
Retinopathy of Prematurity
Registration Number
NCT02157727
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The purpose of this study is to determine whether telemedicine would be as effective as having a pediatrics ophthalmologist on site for screening examination of retinopathy in premature infants and would be cost-effective.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
843
Inclusion Criteria
  • Born before 32 WA or having a birth weight under 1500g
Exclusion Criteria
  • Brain malformations

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of premature infants being screened for retinopathy following recommendations4 weeks in average

Proportion of premature infants being screened for retinopathy following recommendations (between 31 and 32 weeks of amenorrhea (WA) for infants born before 28 WA and during the fourth week of life for infants born after 28 WA)

Secondary Outcome Measures
NameTimeMethod
Cost of telemedicine6 months after enrollment of the first patient
Delay before the first screening of retinopathy4 weeks in average

For infants born at or after 28WA

Trial Locations

Locations (2)

Service de réanimation néonatale. Centre Hospitalier Sud Francilien

🇫🇷

Corbeil-Essonnes, France

Service de réanimation néonatale. Maternité de Port-Royal

🇫🇷

Paris, France

Service de réanimation néonatale. Centre Hospitalier Sud Francilien
🇫🇷Corbeil-Essonnes, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.